CD24 and acute lymphoblastic leukemia: Further characterization of CRISPRMLL-AF4+ proB ALL (the most common type seen in patients) revealed that it recapitulated the immunophenotype of MLL-AF4 infant-ALL, including heterogeneous expression of CD13333, NG237, and CD24 (Fig. 3e and Supplementary Fig. 5c).